Aflibercept in combination with irinotecan and fluorouracil-based therapy for treating metastatic colorectal cancer that has progressed following prior oxaliplatin-based chemotherapy

Technology appraisal guidance
Reference number: TA307
Published: 25 March 2014

Colorectal cancer (metastatic) - aflibercept: Appendix D - response to comments on the draft scope and provisional matrix

Colorectal cancer (metastatic) - aflibercept: Appendix D - response to comments on the draft scope and provisional matrix

Colorectal cancer (metastatic) - aflibercept: Appendix D - response to comments on the draft scope and provisional matrix
02 January 2013
(92.91 Kb 27 sec)

Adobe Acrobat reader required.

Adobe Acrobat reader required.

This page was last updated: 02 January 2013